Market Closed -
Japan Exchange
02:00:00 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1,875
JPY
|
+0.11%
|
|
-1.32%
|
+3.25%
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
21,598
|
19,485
|
19,065
|
27,751
|
22,141
|
24,938
|
Enterprise Value (EV)
1 |
21,247
|
19,347
|
17,455
|
26,095
|
20,453
|
24,057
|
P/E ratio
|
15.1
x
|
13.7
x
|
12.8
x
|
16
x
|
13.2
x
|
16.5
x
|
Yield
|
3.31%
|
3.67%
|
3.75%
|
2.58%
|
4.21%
|
4.36%
|
Capitalization / Revenue
|
1.32
x
|
1.12
x
|
1
x
|
1.32
x
|
0.95
x
|
0.96
x
|
EV / Revenue
|
1.3
x
|
1.11
x
|
0.91
x
|
1.24
x
|
0.88
x
|
0.93
x
|
EV / EBITDA
|
3.36
x
|
2.97
x
|
2.62
x
|
3.53
x
|
2.66
x
|
3.08
x
|
EV / FCF
|
7
x
|
4.04
x
|
2.59
x
|
4.27
x
|
2.84
x
|
3.27
x
|
FCF Yield
|
14.3%
|
24.8%
|
38.6%
|
23.4%
|
35.2%
|
30.5%
|
Price to Book
|
1.76
x
|
1.52
x
|
1.41
x
|
1.9
x
|
1.43
x
|
1.55
x
|
Nbr of stocks (in thousands)
|
15,538
|
15,538
|
15,538
|
15,538
|
15,538
|
15,538
|
Reference price
2 |
1,390
|
1,254
|
1,227
|
1,786
|
1,425
|
1,605
|
Announcement Date
|
6/27/18
|
6/27/19
|
6/26/20
|
6/28/21
|
6/27/22
|
6/29/23
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
16,331
|
17,379
|
19,097
|
21,017
|
23,297
|
25,892
|
EBITDA
1 |
6,326
|
6,524
|
6,664
|
7,395
|
7,679
|
7,816
|
EBIT
1 |
1,877
|
2,079
|
2,156
|
2,613
|
2,327
|
2,118
|
Operating Margin
|
11.49%
|
11.96%
|
11.29%
|
12.43%
|
9.99%
|
8.18%
|
Earnings before Tax (EBT)
1 |
2,101
|
2,086
|
2,144
|
2,518
|
2,377
|
2,127
|
Net income
1 |
1,426
|
1,424
|
1,494
|
1,732
|
1,675
|
1,514
|
Net margin
|
8.73%
|
8.19%
|
7.82%
|
8.24%
|
7.19%
|
5.85%
|
EPS
2 |
91.78
|
91.65
|
96.15
|
111.5
|
107.8
|
97.44
|
Free Cash Flow
1 |
3,034
|
4,793
|
6,743
|
6,116
|
7,204
|
7,346
|
FCF margin
|
18.58%
|
27.58%
|
35.31%
|
29.1%
|
30.92%
|
28.37%
|
FCF Conversion (EBITDA)
|
47.95%
|
73.47%
|
101.18%
|
82.71%
|
93.82%
|
93.98%
|
FCF Conversion (Net income)
|
212.74%
|
336.58%
|
451.33%
|
353.12%
|
430.11%
|
485.19%
|
Dividend per Share
2 |
46.00
|
46.00
|
46.00
|
46.00
|
60.00
|
70.00
|
Announcement Date
|
6/27/18
|
6/27/19
|
6/26/20
|
6/28/21
|
6/27/22
|
6/29/23
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
9,356
|
10,107
|
11,345
|
5,936
|
6,234
|
12,679
|
6,568
|
6,803
|
13,779
|
7,317
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,123
|
1,455
|
1,199
|
612
|
463
|
963
|
665
|
398
|
999
|
584
|
Operating Margin
|
12%
|
14.4%
|
10.57%
|
10.31%
|
7.43%
|
7.6%
|
10.12%
|
5.85%
|
7.25%
|
7.98%
|
Earnings before Tax (EBT)
1 |
1,122
|
1,443
|
1,237
|
623
|
481
|
992
|
658
|
429
|
1,037
|
580
|
Net income
1 |
740
|
957
|
824
|
413
|
315
|
650
|
433
|
279
|
681
|
383
|
Net margin
|
7.91%
|
9.47%
|
7.26%
|
6.96%
|
5.05%
|
5.13%
|
6.59%
|
4.1%
|
4.94%
|
5.23%
|
EPS
2 |
47.63
|
61.61
|
53.04
|
26.59
|
20.32
|
41.86
|
27.86
|
17.98
|
43.86
|
24.65
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/30/19
|
10/29/20
|
10/28/21
|
1/28/22
|
7/29/22
|
10/28/22
|
1/30/23
|
7/28/23
|
10/30/23
|
1/30/24
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
351
|
138
|
1,610
|
1,656
|
1,688
|
881
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
3,034
|
4,793
|
6,743
|
6,116
|
7,204
|
7,346
|
ROE (net income / shareholders' equity)
|
12.1%
|
11.3%
|
11.3%
|
12.3%
|
11.1%
|
9.58%
|
ROA (Net income/ Total Assets)
|
6.74%
|
6.88%
|
7.24%
|
8.54%
|
7%
|
5.95%
|
Assets
1 |
21,163
|
20,693
|
20,639
|
20,286
|
23,923
|
25,442
|
Book Value Per Share
2 |
791.0
|
826.0
|
873.0
|
940.0
|
997.0
|
1,034
|
Cash Flow per Share
2 |
42.00
|
41.10
|
39.30
|
43.60
|
48.10
|
50.90
|
Capex
1 |
184
|
203
|
526
|
344
|
688
|
788
|
Capex / Sales
|
1.13%
|
1.17%
|
2.75%
|
1.64%
|
2.95%
|
3.04%
|
Announcement Date
|
6/27/18
|
6/27/19
|
6/26/20
|
6/28/21
|
6/27/22
|
6/29/23
|
|
1st Jan change
|
Capi.
|
---|
| +3.25% | 185M | | -3.41% | 9.4B | | +30.20% | 1.92B | | -3.90% | 1.39B | | -7.38% | 1.18B | | -18.42% | 857M | | +0.48% | 470M | | +3.62% | 437M | | -49.68% | 360M | | -24.72% | 333M |
Medical Equipment Wholesale
|